Do provincial drug benefit initiatives create an effective policy lab? The evidence from canada

Journal of Health Politics, Policy and Law

Volumn 35, Issue 5, 2010, Pages 705-742

  Pomey, Marie Pascale ^a   Morgan, Steve ^b   Church, John ^c   Forest, Pierre Gerlier ^a   Lavis, John N ^d   McIntosh, Tom ^e   Smith, Neale ^f   Petrela, Jennifer ^a   Martin, Elisabeth ^g   Dobson, Sarah ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF REGINA   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; CANADA; ECONOMICS; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MANAGEMENT; PUBLIC HEALTH;

CANADA; FEDERAL GOVERNMENT; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; NATIONAL HEALTH PROGRAMS; POLICY MAKING; PRESCRIPTION DRUGS; STATE GOVERNMENT;

EID: 78650164095     PISSN: 03616878     EISSN: 15271927     Source Type: Journal    
DOI: 10.1215/03616878-2010-025     Document Type: Article

References (99)

1. Adams, D., ed. 2001. Federalism, Democracy, and Health Policy in Canada. Kingston, ON: McGill-Queen's University Press.
2. Bahan, D., V. Caverivière, B. Decaluwé, C. A. Emini, and A. Lemelin. 2005. Les impacts économiques de la "règle de 15 ans" appliquée au remboursement des médicaments innovateurs au Québec. Quebec: Ministère des Finances.
3. Banting, K., and S. Corbett, eds. 2002. Health Policy and Federalism: A Comparative Perspective on Multi-level Governance. Montreal: McGill-Queen's University Press.
4. Barton, N. W., R. O. Brady, J. M. Dambrosia, A. M. Dibisceglie, S. H. Doppelt, S. C. Hill, H. J. Mankin, et al. 1991. Replacement Therapy for Inherited Enzyme Deficiency - Macrophage- Targeted Glucocerebrosidase for Gaucher's Disease. New England Journal of Medicine 324:1464-1470.
5. Begley, C. E., L. A. Aday, D. R. Lairson, and C. H. Slater. 2002. Expanding the Scope of Health Reform: Application in the United States. Social Science and Medicine 55:1213-1229.
6. Bennett, A., and C. Elman. 2006. Complex Causal Relations and Case Study Methods: The Example of Path Dependence. Political Analysis 14 (3): 250-267.
7. Bennett, C. 1996. Comparative Policy Studies in Canada: What State? What Art? In Policy Studies in Canada: The State of the Art, ed. L. Dobuzinskis, M. Howlett, and D. Laycock, 299-316. Toronto: University of Toronto Press.
8. Berry, F. S., and W. D. Berry. 1992. Tax Innovations in the States: Capitalizing on Political Opportunity. American Journal of Political Science 36:715-742.
9. Beutler, E., A. Kay, A. Saven, P. Garver, D. Thurston, A. Dawson, and B. Rosenbloom. 1991. Enzyme Replacement Therapy for Gaucher Disease. Blood 78:1183-1189.
10. Bhatia, V. 2003. A Cross-provincial Study of Health Care Reform in Canada: Academic Literature Review - Synthesis Paper. Hamilton, ON: McMaster University Centre for Health Economics and Policy Analysis.
11. Boychuk, G. W. 2008. National Health Insurance in the United States and Canada: Race, Territory, and the Roots of Difference. Washington, DC: Georgetown University Press.
12. Brown, D. 2005. Who's Afraid of Asymmetrical Federalism? A Summary Discussion. Kingston, ON: Institute of Intergovernmental Relations, Queen's University.
13. Brown, L. D. 1998. Exceptionalism as the Rule? U.S. Health Policy Innovation and Cross-national Learning. Journal of Health Politics, Policy and Law 23:35-51.
14. Canadian Institute for Health Information (CIHI). 2005. Drug Spending to Reach Almost $22 Billion in 2004, Reports CIHI. News release, April 5. secure.cihi.ca/cihiweb/dispPage.jsp?cw-page=media-05apr2005-e.
15. -2005. Total Drug Expenditure per Capita, Current and Constant Dollars, Canada, 1985 to 2004. secure.cihi.ca/cihiweb/en/media-05apr2005-fig2-e.html (accessed April 10, 2008).
16. -2009. Drug Expenditure in Canada, 1985 to 2008. Ottawa: CIHI. Canadian Pharmacists Association. 2003. Provincial Drug Benefit Programs. 1989-2003. Ottawa: Canadian Pharmacists Association.
17. Comité d'experts sur l'assurance médicaments. 1996. L'assurance médicaments: Des voies de solution. Quebec: Comité d'experts sur l'assurance médicaments.
18. Comité de révision de la circulaire Malades sur pied. 1994. De l'assistance à l'assurance. Québec: Ministère de la Santé et des Services sociaux.
19. Coombes, M. E., S. G. Morgan, M. L. Barer, and N. Pagliccia. 2004. Who's the Fairest of Them All? Which Provincial Pharmacare Model Would Best Protect Canadians against Catastrophic Drug Costs? Longwoods Review 2 (3): 13-36.
20. Creswell, J. W. 2003. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. 2nd ed. Thousand Oaks, CA: Sage.
21. Demers, V., M. Melo, C. Jackevicius, J. Cox, D. Kalavrouziotis, S. Rinfret, K. H. Humphries, H. Johansen, J. V. Tu, and L. Pilote. 2008. Comparison of Provincial Prescription Drug Plans and the Impact on Patients' Annual Drug Expenditures. Canadian Medical Association Journal 178:405-409.
22. Dunn, W., ed. 1998. The Experimenting Society: Essays in Honor of Donald T. Campbell. New Brunswick, NJ: Transaction Publishers.
23. Figueroa, M. L., B. E. Rosenbloom, A. C. Kay, D. W. Thurston, J. A. Koziol, T. Gelbart, and E. Beutler. 1992. A Less Costly Regimen of Alglucerase to Treat Gaucher's Disease. New England Journal of Medicine 327:1632-1636.
24. Forest, P.-G. 2007. Santé: En finir avec la chaise vide. In Reconquérir le Canada: Un nouveau projet pour la nation québécoise, ed. A. Pratte, 261-285. Montreal: Éditions voix parallèles.
25. Forest, P.-G., and K. M. Bergeron. 2005. Les politiques de réforme du système de santé dans cinq fédérations: Une analyse de travaux scientifiques récents. In Politiques publiques comparées dans les États fédérés: L'Allemagne, l'Australie, le Canada, les États-Unis et la Suisse, ed. L. Imbeau, 59-90. Sainte-Foy: Les Presses de l'Université Laval.
26. Government of British Columbia, Ministry of Health. 2003. What Is Fair Pharma-Care. www.healthservices.gov.bc.ca/pharme/plani/planiinfo.html (accessed April 8, 2008).
27. Grootendorst, P. 2002. Beneficiary Cost Sharing under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment. Canadian Journal of Clinical Pharmacology 9:79-99.
28. Hall, P. 1997. The Role of Interests, Institutions, and Ideas in the Comparative Political Economy of the Industrialized Nations. In Comparative Politics: Rationality, Culture, and Structure, ed. M. I. Lichbach and A. S. Zucherman, 174-207. Cambridge: Cambridge University Press.
29. Hall, P., and R. Taylor. 1996. Political Science and the Three New Institutionalisms. Political Studies 44:936-957.
30. Health Canada. 2009. 2003 First Ministers Health Accord: Pharmaceuticals Management and Catastrophic Drug Coverage. www.hc-sc. gc.ca/hcs-sss/delivery -prestation/fptcollab/2003accord/pharma-eng. php (accessed February 9, 2010).
31. Hebert, P. C. 2009. An Open Letter to the Minister of Health. Canadian Medical Association Journal 180:903.
32. Heinrich, J. 1996. Architect of Drug Program Supports Government's Changes. Gazette, June 13.
33. Heuglin, T. O. 1986. Federalism and Fragmentation: A Comparative View of Political Accommodation. Kingston, ON: Institute of Government, Queen's University.
34. Hickey, D. J. 2004. The Evolution of Public Drug Benefits in Saskatchewan: 1945 - 2002. In Student Public Policy Essays, ed. Saskatchewan Institute of Public Policy. Regina: University of Regina Press.
35. Hollis, A., and S. Law. 2004. A National Formulary for Canada. Canadian Public Policy 30:445-452.
36. Houston, S. 2002. Steps on the Road to Medicare: Why Saskatchewan Led the Way. Montreal: McGill-Queen's University Press.
37. Human Resources and Social Development Canada. 2007. Pharmaceutical and Medicine Industry: Background Information. www.hrsdc.gc.ca/en/hip/hrp/sp/ industry-profiles/pharmaceutical-medicine.shtml (accessed July 1, 2007).
38. Imbeau, L., R. Landry, H. Milner, F. Pétry, J. Crête, P.-G. Forest, and V. Lemieux. 2000. Comparative Provincial Policy Analysis: A Research Agenda. Canadian Journal of Political Science 33:779-804.
39. IMS Health. 2007. Canadian Internet Pharmacy Sales to the United States Down 50 Percent in 2006. News release, March 19. www.imshealth.com/portal/site/ imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=d1d6ef 8282f75210VgnVCM10000071812ca2RCRD&vgnextchannel=41a67900b55a5110 VgnVCM10000071812ca2RCRD&vgnextfmt=default.
40. Institute of Intergovernmental Relations. 2009. Cross-Provincial Comparison of Health Care Policy Reform in Canada. Queen's University. www.queensu.ca/iigr/Res/crossprov.html (accessed January 14, 2010).
41. Ipsos Canada. 2006. Canadians on Healthcare. News release, January 18. www.ipsos -na. com/news-polls/pressrelease.aspx?id=2943.
42. Jean, M. 2007. Speech from the Throne. October 16. www.ctv.ca/servlet/ ArticleNews/story/CTVNews/20071016/thronespeech-SIDEBARS-071016/20071016.
43. Kapur, V., and K. Basu. 2005. Drug Coverage in Canada: Who Is at Risk? Health Policy 71:181-193.
44. Kiassen, T. R., and D. Buchanan. 2006. Ideology, Policy, and Economy: Liberal, New Democratic, and Conservative Reforms of Ontario's Welfare Program. Journal of Canadian Studies 40 (3): 186-210.
45. Lavis, J. N., S. E. Ross, J. E. Hurley, J. M. Hohenadel, G. L. Stoddart, C. A. Woodward, and J. Abelson. 2002. Examining the Role of Health Services Research in Public Policymaking. Milbank Quarterly 80:125-154.
46. Liberal Party of Canada. 2004. Moving Canada Forward: The Paul Martin Plan for Getting Things Done. Ottawa: Liberal Party of Canada.
47. -2006. Securing Canada's Success: Liberal Party of Canada Platform. Ottawa: Liberal Party of Canada.
48. Mackinnon, J. 2003. Minding the Public Purse: The Fiscal Crisis, Political Trade- offs, and Canada's Future. Montreal: McGill-Queen's University Press.
49. Mahoney, J. 2000. Path Dependence in Historical Sociology. Theory and Society 29:507-548.
50. Maioni, A. 1995. Nothing Succeeds Like the Right Kind of Failure: Postwar National Health Insurance in Canada and the United States. Journal of Health Politics, Policy and Law 20:5-30.
51. -1998. Parting at the Crossroads: The Emergence of Health Insurance in the United States and Canada. Princeton, NJ: Princeton University Press.
52. Marmor, T. R. 1997. Global Health Policy Reform: Misleading Mythology or Learning Opportunity. In Health Policy Reform, National Variations, and Globalization, ed. C. Altenstetter and W. Björkman, 348-364. New York: St. Martin's Press and IPSA.
53. Marshall, C., and G. B. Rossman. 1999. Designing Qualitative Research. 3rd ed. Thousand Oaks, CA: Sage.
54. McMahon, M., S. Morgan, and C. Mitton. 2006. The Common Drug Review: A NICE Start for Canada? Health Policy 77:339-351.
55. Mickleburgh, R. 1993. Dying Man Makes Plea for Drug Funding. Activist AIDS Patient Uses Video to Attack Health Ministry Policies. Globe and Mail, January 7.
56. Ministry of Health and Long-Term Care. 1993. Consultation Paper Discusses Fairer Drug Benefit Program. June 29. Toronto: Ministry of Health and Long-Term Care.
57. Morgan, S., M. L. Barer, and J. D. Agnew. 2003. Whither Seniors' Pharmacare: Lessons from (and for) Canada. Health Affairs 22 (3): 49-59.
58. Morgan, S., K. Bassett, and B. Mintzes. 2004. Outcomes-Based Drug Coverage in British Columbia. Health Affairs 23 (3): 269-276.
59. British Columbia. Health Affairs 23 (3): 269 - 276. Morgan, S., and M. Coombes. 2006. Income-Based Drug Coverage in British Columbia: Towards an Understanding of the Policy. Healthcare Policy 2 (2): 92-108.
60. Morgan, S. G., K. L. Bassett, R. G. Wright, R. Evans, M. L. Barer, P. A. Caetano, and C. D. Black. 2005. "Breakthrough" Drugs and Growth in Expenditure on Prescription Drugs in Canada. BMJ 331:815-816.
61. Morgan, S. G., G. Hanley, C. Raymond, and R. Blais. 2009. Breadth, Depth, and Agreement among Provincial Drug Formularies in Canada. Healthcare Policy 4 (4): e162-e184. www.longwoods.com/content/20685.
62. National Forum on Health. 1997. Canada Health Action: Building on the Legacy. Vol. 1, Final Report of the National Forum on Health. Ottawa: National Forum on Health.
63. Neale, S., W. N. Palmer, and A. Salazar. 2003. The Pharmaceutical Pricing, Reimbursement, and Prescribing Environment in Canada. Decision Resources.
64. Oliver, T. R. 2000. Commentary: Dynamics without Change: The New Generation. Journal of Health Politics, Policy and Law 25:225-232.
65. Patented Medicine Prices Review Board. 2004-2005. Departmental Performance Report. www.collectionscanada.gc.ca/webarchives/20060116230539/www. tbs-sct.gc.ca/rma/dpr1/04-05/0405dpr-rmr-e.asp (accessed April 8, 2008).
66. Patton, M. Q. 1990. Qualitative Evaluation and Research Methods. Newbury Park, CA: Sage.
67. Pierson, P. 2000. Increasing Returns, Path Dependence, and the Study of Politics. American Political Science Review 94:251-267.
68. Policy Advisory Committee on Long Term Care. 1999. Healthy Aging, New Directions for Care. Final Report. Edmonton: Alberta Health and Wellness.
69. Pomey, M.-P., P.-G. Forest, H. Palley, and E. Martin. 2007. Public/Private Partnerships for Prescription Drug Coverage: Policy Formulation and Outcomes in Quebec's Universal Drug Insurance Program, with Comparisons to the Medicare Prescription Drug Program in the United States. Milbank Quarterly 85:469-498.
70. Pomey, M.-P., and E. Martin. Forthcoming. Quebec Reforms from Rochon to Couillard: The Long and Winding Road. In Health Care Reforms in Canada: 1990 to 2004, ed. H. Lazar, J. N. Lavis, and P.-G. Forest.
71. Presse Canadienne. 1996. Assurance-médicaments: Modification au régime. La Presse, August 2.
72. Record (Kingston, ON). 1993. Province OKs Limited Funds for Costly Gaucher Drug. N.d.
73. Régie de l'assurance maladie du Québec (RAMQ). 1998. Évolution des principaux facteurs de coût du programme de médicaments et de services pharmaceutiques et du régime d'assurance médicaments, Québec, 1994-1998. https://www.prod .ramq.gouv.qc.ca/IST/CD/CDF-DifsnInfoStats/CDF1-CnsulInfoStatsCNC-iut/RappPDF. aspx?TypeImpression=pdf&NomPdf=CCB2R01A-AM04-1998-0-O .pdf (accessed April 10, 2008).
74. -1998-1999. Le régime général d'assurance médicaments: Rapport d'activité 1998-1999. Quebec: RAMQ. www.ramq.gouv.qc.ca/fr/publications/documents/rapp9899/ass-med9899.pdf.
75. -2005. Évolution des principaux facteurs de coût, 2000 - 2004 - Régime public d'assurance médicaments, Québec, 2004. https://www.prod.ramq.gouv .qc.ca/IST/CD/CDF-DifsnInfoStats/CDF1- CnsulInfoStatsCNC-iut/RappPDF.aspx ?TypeImpression=pdf&NomPdf=CCB2R01A-AM04- 2004-0-O.pdf (accessed April 10, 2008).
76. Reinharz, D., L. Rousseau, and S. Rheault. 1999. La place du médicament dans le système de santé du Québec. In Le système de santé québécois: Un modèle en transformation, ed. C. Bégin, P. Bergeron, P.-G. Forest, and V. Lemieux, 149-167. Montreal: Les Presses de l'Université de Montréal.
77. Remis, R. S., C. Major, H. Bangura, E. Wallace, and M. Vermeulen. 1998. Report on the HIV/AIDS Epidemic in Ontario, 1981-1996. July. Toronto: Ontario Ministry of Health.
78. Roberts, D. 1997. Premier Reveals Saskatchewan Flirted with Bankruptcy Undisclosed Federal Bailout Averted Crisis in 1993. Globe and Mail, March 22.
79. Romanow, R. J. 2002. Building on Values: The Future of Health Care in Canada. Ottawa: Commission on the Future of Health Care in Canada.
80. Royal Commission on Health Services. 1964. Royal Commission on Health Services: 1964. 2 vols. Ottawa: Queen's Printer.
81. Sparer, M. S. 1997. Laboratories and the Health Care Marketplace: The Limits of State Workforce Policy. Journal of Health Politics, Policy and Law 22:789-814.
82. Sparer, M. S., and L. D. Brown. 1996. The Limits and Lessons of the Laboratory of Federalism. In Health Policy, Federalism, and the American States, ed. R. E. Rich and W. D. White, 181 - 202. Washington, DC: Urban Institute Press.
83. Standing Senate Committee on Social Affairs, Science, and Technology. 2002. The Health of Canadians: The Federal Role. Final Report. Ottawa: Parliament of Canada. Statistics Canada. 1996. 1996 Census of Population. Ottawa: Statistics Canada.
84. -2001. Population and Dwelling Counts, for Canada, Provinces and Territories, 1991 and 1996 Censuses - 100 Percent Data. www.statcan.ca/english/ census96/table1.htm (accessed September 19, 2007).
85. -2006. 2006 Census of Population. Ottawa: Statistics Canada.
86. Stream, C. 1999. Health Reform in the States: A Model of State Small Group Health Insurance Market Reforms. Political Research Quarterly 52:499-525.
87. Sullivan, T. 2007. Between the Dream and Sleepwalking. In Exploring Social Insurance: Can a Dose of Europe Cure Canadian Health Care Finance?, ed. C. M. Flood, M. Stabile, and C. H. Tuohy, 221-232. Montreal and Kingston: McGill- Queen's University Press.
88. Tamblyn, R., R. Laprise, J. A. Hanley, M. Abrahamowicz, S. Scott, N. Mayo, J. Hurley, et al. 2001. Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons. Journal of the American Medical Association 285:421-429.
89. Taylor, B. 1993. The High Cost of Living. Toronto Star, January 14.
90. Taylor, M. G. 1987. Health Insurance and Canadian Public Policy: The Seven Decisions That Created the Canadian Healthcare System. Montreal and Kingston: McGill-Queen's University Press.
91. Thompson, E. 1997. Quebec Cushions New Drug Plan: Health Minister Jean Rochon Reverses Himself, Changing His New Drug-Insurance Plan in a Bid to Soften the Blow to Poor Beneficiaries. Gazette, June 7.
92. Tuohy, C. H. 1999a. Accidental Logics: The Dynamics of Change in the Health Care Arena in the United States, Britain, and Canada. New York: Oxford University Press.
93. -1999b. Dynamics of a Changing Health Sphere: The United States, Britain, and Canada. Health Affairs 18 (3): 114-134.
94. United Nations Statistics Division. 2003. Population and Vital Statistics Report. unstats.un.org/unsd/seriesa/introduction.asp (accessed April 8, 2008).
95. Van Loon, R., and M. S. Whittington. 1987. The Canadian Political System: Environment, Structure, and Process. Toronto: McGraw-Hill Ryerson.
96. Venne, M. 1996. Rochon devra couper 80 millions de plus dans le système de santé. Le Devoir, July 4.
97. Wilson, K. 2000. Health Care, Federalism, and the New Social Union. Canadian Medical Association Journal 162:1171-1174.
98. Wright, J. 2006. Public Rx's. Paper presented to Environment for Pharmaceutical Change in Canada: Challenge and Opportunities, Canadian Health Policy Implementation Initiative, Kingbridge Centre, King City, Ontario, April 25.
99. Yin, R. K. 2003. Case Study Research: Design and Methods. 3rd ed. Thousand Oaks, CA: Sage.